Anesthetics inhibit high‐affinity states of dopamine D2 and other G‐linked receptors
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The high‐affinity states of dopamine D2 and D3 receptors, serotonin 5HT‐2A receptors, beta‐2‐adrenoceptors, alpha‐1 and alpha‐2 adrenoceptors, opiate receptors, and muscarinic receptors were inhibited by clinical concentrations of anesthetics, including isoflurane, halothane, chloral hydrate, ketamine, and ethanol. The inhibition occurred not only in vitro, but also in vivo in rats anesthetized with isoflurane, with the high‐affinity states recovering at different rates. Because the high‐affinity states of G‐protein‐linked receptors are physiologically functional, their general inhibition by clinical concentrations of anesthetics may underlie general anesthesia and may explain some of the side effects of anesthetics. Subanesthetic concentrations of the anesthetics, including ketamine, stimulated the incorporation of GTP into the cloned dopamine D2 receptors. It is possible that the classical stage 2 excitement phase which occurs with subanesthetic concentrations of general anesthetics and ketamine may be associated with this general stimulation of a variety of G‐protein‐linked receptors, as found in the present study, while the stage 3 level of surgical anesthesia may be associated with the inhibition of the high‐affinity states of several receptors. Synapse 50:35–40, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459 · cited 9×
“The addition of 200 M guanilylimidodiphosphate (Gpp[NH]p) eliminated the high-affinity component, but had no effect on the low-affinity site (data not shown; see Kapur and Seeman, 2002).”
BackgroundMethodInfluentialSelf-citationBioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710516 · Cited by 420 · cited 2×
“The alleviation of pain in humans occurs above 0.67 M ketamine in plasma (Clements et al., 1982), with psychotic effects occurring between 0.5 and 1 M ketamine (Bowdle et al., 1998).”
BackgroundInfluential
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Psychosis pathways converge via D2High dopamine receptors
Seeman, P., Schwarz, J., Chen, J.-F., Szechtman, H., Perreault, M., McKnight, G. S., Roder, J. C., Quirion, R., Boksa, P., Srivastava, L. K., et al. (2006) · Synapse · doi:10.1002/syn.20303 · Cited by 330
Self-citationPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Thanos, P. K., Michaelides, M., Piyis, Y. K., Wang, G., & Volkow, N. D. (2008) · Synapse · doi:10.1002/syn.20468 · Cited by 135
An open-label, flexible-dose study of memantine in major depressive disorder
Ferguson, J. M., & Shingleton, R. N. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180314ae7 · Cited by 113
Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110
“Seeman and Kapur (2003) have reported that high concentrations of ketamine converted the D2 receptor from high to low affinity state.”
BackgroundThanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.020 · Cited by 100
“It has previously been shown that surgical concentrations of isoflurane, halothane, ethanol and ketamine inhibit high affinity states of the D2R as well as other G-protein linked receptors in-vitro (Kapur and Seeman, 2002; Seeman and Kapur, 2003).”
BackgroundHalothane binding proteome in human brain cortex
Pan, J. Z., Xi, J., Tobias, J. W., Eckenhoff, M. F., & Eckenhoff, R. G. (2007) · Journal of Proteome Research · doi:10.1021/pr060311u · Cited by 49
Pedersen, K., Simonsen, M., Østergaard, S. D., Lajord Munk, O., Rosa-Neto, P., Olsen, A. K., Jensen, S. B., Møller, A., & Cumming, P. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.038 · Cited by 37
Metadata
- Authors
- Seeman, P., & Kapur, S.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2003-07
- Volume
- 50
- Issue
- 1
- Pages
- 35-40
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2058426499
- Cited by
- 68
- References
- 2
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.